Li Ma from 7131 Tulane Ave, Saint Louis, MO 63130, age 52, Phone: (314)7265716

Medicine Doctors

Li Ma

view source

Specialties:

Anesthesiology, Pain Management

Work:

Interventional Pain Physicians
5304 Main St, New Port Richey, FL 34652
(727)5978430 (phone), (727)5978431 (fax)

Education:

Medical School
Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71)
Graduated: 1988

Languages:

English
Spanish

Description:

Dr. Ma graduated from the Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71) in 1988. She works in New Port Richey, FL and specializes in Anesthesiology and Pain Management.

Li Ma

view source

Specialties:

Anatomic Pathology & Clinical Pathology

Work:

Southeastern Pathology Associates
203 Indigo Dr, Brunswick, GA 31525
(912)2612669 (phone), (912)2610561 (fax)

Education:

Medical School
Xuzhou Med Coll, Xuzhou City, Jiangsu, China
Graduated: 1982

Languages:

English

Description:

Dr. Ma graduated from the Xuzhou Med Coll, Xuzhou City, Jiangsu, China in 1982. He works in Brunswick, GA and specializes in Anatomic Pathology & Clinical Pathology.

Li Ma

view source

Us Patents

Treating Bax(Delta)2-Positive Cancer With Chemotherapies Targeting Caspase 8
view source
US Patent:

20170108504, Apr 20, 2017
Filed:

Aug 24, 2016
Appl. No.:

15/245966
Inventors:

- Saint Charles IL, US
Li Ma - Chicago IL, US
International Classification:

G01N 33/574
A61K 31/17
C12Q 1/68
A61K 31/513
Abstract:

Discovery of a new Bax isoform, BaxΔ2, in cancer cell lines and primary tumors is described. The BaxΔ2 isoform resulted from combination of Bax microsatellite mutation and alternative splicing Bax exon 2. It is also discovered that BaxΔ2 renders cancer cells sensitive to certain chemotherapeutic drugs that target caspase 8. Also provided are methods for treating colorectal cancer by administering to a colorectal cancer patient a chemotherapeutic agent that is capable of activating caspase 8, wherein the patient contains a cancer cell that expresses a BaxΔ2 protein (SEQ ID NO. 2).

Treating Bax(Delta)2-Positive Cancer With Chemotherapies Targeting Caspase 8
view source
US Patent:

20150111911, Apr 23, 2015
Filed:

Aug 14, 2014
Appl. No.:

14/460352
Inventors:

Jialing Xiang - Chicago IL, US
Li Ma - Chicago IL, US
Assignee:

Mumetel, LLC - Saint Charles IL
International Classification:

A61K 31/513
A61K 45/06
A61K 31/17
US Classification:

514274, 514588
Abstract:

Discovery of a new Bax isoform, BaxΔ2, in cancer cell lines and primary tumors is described. The BaxΔ2 isoform resulted from combination of Bax microsatellite mutation and alternative splicing Bax exon 2. It is also discovered that BaxΔ2 renders cancer cells sensitive to certain chemotherapeutic drugs that target caspase 8. Also provided are methods for treating colorectal cancer by administering to a colorectal cancer patient a chemotherapeutic agent that is capable of activating caspase 8, wherein the patient contains a cancer cell that expresses a BaxΔ2 protein (SEQ ID NO. 2).